The Stargate Project, a $500B initiative focused on artificial intelligence, lifted AI-driven biotech stocks this week while boosting an unlikely winner, Metagenomi (NASDAQ:MGX), which benefitted from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback